Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same author

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.

Frontiers in immunology·2026
Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026
Same author

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

British journal of haematology·2026
Same author

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Haematologica·2026
Same author

Effect of heart rate reduction with ivabradine on quality of life in advanced cancer patients.

ESC heart failure·2026

Related Experiment Video

Updated: Oct 9, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.9K

Advances in Lymphoma Molecular Diagnostics.

Igor Age Kos1, Lorenz Thurner1, Joerg Thomas Bittenbring1

  • 1Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, 66424 Homburg, Germany.

Diagnostics (Basel, Switzerland)
|December 24, 2021
PubMed
Summary

Molecular diagnostics are vital for understanding lymphomas, a diverse group of cancers. Advances in identifying genetic alterations improve diagnosis, risk stratification, and targeted treatments for lymphoid neoplasms.

Keywords:
lymphoma diagnosticsmolecular diagnosticsnon-Hodgkin lymphomasequencing

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.9K

Related Experiment Videos

Last Updated: Oct 9, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.9K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Diagnostics

Background:

  • Lymphomas are diverse malignant lymphoid neoplasms with numerous reported genetic alterations.
  • Molecular changes are increasingly integrated into diagnostic criteria by the World Health Organization.
  • Accurate identification of these alterations is crucial for patient management.

Purpose of the Study:

  • To provide an overview of advances in molecular diagnostic techniques for lymphomas.
  • To discuss the clinical implications of these molecular alterations.
  • To highlight the impact of molecular diagnostics on lymphoma treatment strategies.

Main Methods:

  • Review of current scientific literature on lymphoma molecular diagnostics.
  • Discussion of established and emerging molecular techniques.
  • Clinical case examples illustrating the application of molecular findings.

Main Results:

  • A wide spectrum of genetic alterations has been identified across lymphoma subtypes.
  • Molecular diagnostics are essential for accurate classification and risk stratification.
  • Targeted therapies based on specific molecular alterations are transforming treatment.

Conclusions:

  • Advances in molecular diagnostics are critical for the comprehensive evaluation of lymphomas.
  • Molecular profiling aids in personalized treatment approaches and improved patient outcomes.
  • Continued research and integration of molecular techniques are vital for advancing lymphoma care.